Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia.
Gruel
Y
Y
Boizard-Boval
B
B
Wautier
J L
JL
D001323:Autoantibodies / Q000276:immunology / Q000378:metabolism*; D001327:Autoimmune Diseases / Q000097:blood*; D001606:Bernard-Soulier Syndrome / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D006493:Heparin / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology / Q000378:metabolism*; D015539:Platelet Activation; D010978:Platelet Factor 4 / Q000502:physiology*; D010980:Platelet Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013915:Thrombasthenia / Q000097:blood; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*
D001323:Autoantibodies; D007074:Immunoglobulin G; D010980:Platelet Membrane Glycoproteins; D012701:Serotonin; D010978:Platelet Factor 4; D006493:Heparin